EP3778641
TVÍSÉRTÆKAR MÓTEFNAVAKA-BINDANDI SAMEINDIR SEM BINDAST CD3 OG CD20 OG GAGNSEMI ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.9.2013EP published:
8.11.2023EP application number:
20186993.0
EP translation filed:
28.11.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
18.9.2033Expiry date:
18.9.2026Next due date:
30.9.2026
Title in English:
BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOFLanguage of the patent:
English
Timeline
Today
19.9.2013EP application
8.11.2023EP Publication
28.11.2023Translation submitted
15.1.2024Registration published
18.9.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
SMITH, EricAddress:
New York, NY 10016, US
Name:
PAPADOPOULOS, Nicholas JAddress:
Lagrangeville, NY 12540, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201261704029 PDate:
21.9.2012Country:
US
Number:
201361753461 PDate:
17.1.2013Country:
US
Number:
201361763110 PDate:
11.2.2013Country:
US
Number:
201361827098 PDate:
24.5.2013Country:
US
Classification
Categories:
C07K 16/28, A61K 39/00, A61K 39/395, A61P 35/00, A61P 35/02, A61P 37/04
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 22.8.2024
Expires: 18.9.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 15.9.2025
Expires: 18.9.2026
Payer: Árnason Faktor ehf.